Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Sergeant

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Journal of Virology|August 19, 2007
Protein kinase CK2 phosphorylation of EB2 regulates its function in the production of Epstein-Barr virus infectious viral particlesCahora Medina-Palazon, Henri Gruffat, Fabrice Mure, et al.
Journal of Neurochemistry|June 6, 2003
Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approachNicolas Sergeant, Stepanie Bombois, Antoine Ghestem, et al.
Asian Journal of Andrology|September 16, 2014
Immunodetection of Tau microtubule-associated protein in human sperm and testisJulien Sigala, Fanny Jumeau, Marie-Laure Caillet-Boudin, et al.
Rare Diseases (Austin, Tex.)|July 9, 2014
Synaptic protein dysregulation in myotonic dystrophy type 1: Disease neuropathogenesis beyond missplicingOscar Hernández-Hernández, Géraldine Sicot, Diana M Dinca, et al.
Human Molecular Genetics|July 28, 2010
Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegenerationSébastien S Hébert, Aikaterini S Papadopoulou, Pascal Smith, et al.
Journal of Neuroscience Research|July 25, 2006
ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type IOlivier Leroy, Claire-Marie Dhaenens, Suzanna Schraen-Maschke, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2016
Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy BodiesNicolas R Barthélemy, Audrey Gabelle, Christophe Hirtz, et al.
Journal of Proteome Research|January 9, 2016
Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure HeterogeneityNicolas R Barthélemy, François Fenaille, Christophe Hirtz, et al.
Current Alzheimer Research|January 26, 2012
Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approachLaetitia Troquier, Raphaelle Caillierez, Sylvie Burnouf, et al.
The Journal of Biological Chemistry|May 1, 2007
Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodiesValérie Vingtdeux, Malika Hamdane, Anne Loyens, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Journal of Virology|August 19, 2007
Protein kinase CK2 phosphorylation of EB2 regulates its function in the production of Epstein-Barr virus infectious viral particlesCahora Medina-Palazon, Henri Gruffat, Fabrice Mure, et al.
Journal of Neurochemistry|June 6, 2003
Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approachNicolas Sergeant, Stepanie Bombois, Antoine Ghestem, et al.
Asian Journal of Andrology|September 16, 2014
Immunodetection of Tau microtubule-associated protein in human sperm and testisJulien Sigala, Fanny Jumeau, Marie-Laure Caillet-Boudin, et al.
Rare Diseases (Austin, Tex.)|July 9, 2014
Synaptic protein dysregulation in myotonic dystrophy type 1: Disease neuropathogenesis beyond missplicingOscar Hernández-Hernández, Géraldine Sicot, Diana M Dinca, et al.
Human Molecular Genetics|July 28, 2010
Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegenerationSébastien S Hébert, Aikaterini S Papadopoulou, Pascal Smith, et al.
Journal of Neuroscience Research|July 25, 2006
ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type IOlivier Leroy, Claire-Marie Dhaenens, Suzanna Schraen-Maschke, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2016
Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy BodiesNicolas R Barthélemy, Audrey Gabelle, Christophe Hirtz, et al.
Journal of Proteome Research|January 9, 2016
Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure HeterogeneityNicolas R Barthélemy, François Fenaille, Christophe Hirtz, et al.
Current Alzheimer Research|January 26, 2012
Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approachLaetitia Troquier, Raphaelle Caillierez, Sylvie Burnouf, et al.
The Journal of Biological Chemistry|May 1, 2007
Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodiesValérie Vingtdeux, Malika Hamdane, Anne Loyens, et al.
Pageof 10